Table 2. Amino acid sequence of different CCK2R targeting peptide analogs suitable for labelling with radiometals.
Peptide analog | Amino acid sequence |
---|---|
DTPA-minigastrin | DTPA-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-sCCK8 | DOTA-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-CCK | DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 |
DTPA-CCK | DTPA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 |
DTPA-MG0 | DTPA-DGlu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-MG0 | DOTA-DGlu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-MG11 | DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-G-CCK8 | DOTA-Gly-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 |
SA106 | DOTA-DAsp-Phe(p-CH2SO3H)-HPG-Gly-Trp-HPG-Asp-Phe-NH2 * |
Sargastrin | DOTA-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2 |
APH070 | DOTA-His-His-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-cyclo-MG1 | DOTA-cyclo[γ-D-Glu-Ala-Tyr-D-Lys]-Trp-Met-Asp-Phe-NH2 |
DOTA-cyclo-MG2 | DOTA-cyclo[γ-D-Glu-Ala-Tyr-D-Lys]-Trp-Nle-Asp-Phe-NH2 |
MGD5 | DOTA-Gly-Ser-Cys-(Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2)2 |
DOTA-PP-F6 | DOTA-DGln-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-PP-F10 | DOTA-DGln-DGln-DGln-DGln-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-PP-F16 | DOTA-DGln-DGlu-DGln-DGlu-DGln-DGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-PP-F11/CP04 | DOTA-DGlu-DGlu-DGlu-DGlu-DGlu-DGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-PP-F11-L | DOTA-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
DOTA-PP-F11N | DOTA-DGlu-DGlu-DGlu-DGlu-DGlu-DGlu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2 |
HPG = homopropargylglycine